| Kari Ellefson, | |
|
15802 N Parkview Pl, Surprise, AZ 85374-7466 | |
| (623) 876-7923 | |
| Not Available |
| Full Name | Kari Ellefson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 15802 N Parkview Pl, Surprise, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104293554 | NPI | - | NPPES |
| TSLP9544 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | TSLP9544 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kari Ellefson, 15802 N Parkview Pl, Surprise, AZ 85374-7466 Ph: (623) 876-7923 | Kari Ellefson, 15802 N Parkview Pl, Surprise, AZ 85374-7466 Ph: (623) 876-7923 |
News Archive
Life Technologies Corporation today announced the launch of its TaqMan Mutation Detection Assays - highly sensitive and novel molecular analysis research tools with the precision to detect a single mutant molecule hiding in a background of 1 million normal copies.
LifeGen Technologies, LLC has been awarded a Phase I Small Business Innovative Research grant from the United States National Institute on Aging. The project is focused on identifying a robust panel of genes in adipose tissue (fat) that are regulated by a calorie restricted diet. According to Dr. Jamie Barger, Director of Operations at LifeGen, the technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue in a manner similar to that of a calorie restricted diet.
In a new study of one of the most common genetic causes of autism, neuroscientists at MIT's Picower Institute for Learning and Memory have identified a specific molecular mechanism that appears to undermine the ability of neurons in affected mice to properly incorporate changes driven by experience.
Researchers at the Jules Bordet Institute - Université libre de Bruxelles, VIB and KU Leuven published this 21 of April an important study offering a better understanding of the progression of breast cancer.
Telesta Therapeutics Inc. announced today that it has received its BLA Filing Notification for MCNA from the U.S. Food and Drug Administration. This formal letter communicates that the FDA has completed its initial review of Telesta's Biologics License Application (BLA) submitted on June 29, 2015 and has accepted it for filing.
› Verified 2 days ago
Rachelle Brandt, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15301 N 138th Ln, Surprise, AZ 85379 Phone: 480-600-4077 | |
Miss Dana Messer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13601 N Litchfield Rd Ste 124, Surprise, AZ 85379 Phone: 800-376-3440 | |
Madison Thielen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13601 N Litchfield Rd Ste 124, Surprise, AZ 85379 Phone: 623-259-9819 | |
Jessica Solari, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15802 N Parkview Pl, Surprise, AZ 85374 Phone: 623-876-7000 | |
Sierra B De Angelis, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13601 N Litchfield Rd Ste 124, Surprise, AZ 85379 Phone: 623-322-8250 | |
Catalyst Speech Therapy & Diagnostics Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18213 N Skyhawk Drive, Surprise, AZ 85374 Phone: 623-363-1533 |